At present, it is unclear if additional phenotypes are seen in the proband (e.g., white matter loss, kidney stones, bronchopulmonary dysplasia, etc., see Table 1) can be linked to MYL9, and additional genetic testing has not been performed. The gene discussed is MYL9; the disease is nephrolithiasis.